Thomas has been serving as the Senior Vice President of Cell Therapy Development and Operations at BMS since August 2023. Before joining BMS, he held multiple roles with Merck & Co, where he gained experience in basic research, early and late-stage process development, capital project management, site-based technical operations, commercialization, manufacturing science and technology, and supply chain. Before that, Thomas worked for startup, GlycoFi, founded at Dartmouth College, where he conducted post-doctoral research after receiving his PhD in Bioprocess Engineering from the University of Cape Town in South Africa.

Thomas is an energetic, outcome-driven leader with a broad biopharmaceutical background and hands-on experience in drug discovery, lead molecule optimization, early and late-stage bioprocess development, technology transfer, pre-clinical development, regulatory submissions, commercialization, manufacturing, and business development. His engineering experience includes conceptual and detailed design, construction management, commissioning, and sustainable operation of bioprocess facilities. Thomas excels at leading cross-functional manufacturing teams to ensure the reliable production of life-saving medicines. He builds strong interpersonal relationships using an open, trust-driven, and team-focused management style.

Outside of work, Thomas enjoys spending time with his wife, Liana, and their two daughters. If he's not working or with his family, he can be found fixing up a house, doing something outside, or pretending to be a carpenter.